RLMD 0.63 (-77.26%)
US75955J4022• Drug Manufacturers• Drug Manufacturers - Specialty & Generic
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. RLMD

Relmada Therapeutics (RLMD) Competitor Comparison

We are evaluating the key criteria listed to compare Relmada Therapeutics (RLMD) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Market Capitalization

35 / 54

Gross Profits

0 / 39

Total Revenue

0 / 50

EBITDA

0 / 53

Free Cashflow

46 / 54

Quick Ratio

4 / 54

Earnings per Share

48 / 54

Dividend yield

0 / 5

Total Cash

24 / 54

Performance 3 years

42 / 54

Performance 5 years

46 / 54

Performance 10 years

47 / 54

Linearity 3 years

30 / 54

Linearity 5 years

38 / 54

Linearity 10 years

45 / 54

Total Rank

52 / 54

Dividend Rank

32 / 54

Valuation Rank

45 / 54

Piotroski Rank

45 / 54

Muliplier Rank

51 / 54

Linearity 3 years - RLMD ranking 30 / 54

These are the competitors of Relmada Therapeutics in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Kamada KMDA
27.95
2. Kolinpharma KIP.MI
11.59
3. Perrigo PRGO
10.78
4. Alvotech ALVO
9.88
5. Alimera Sciences ALIM
8.97
6. Supernus Pharmaceuticals SUPN
8.68
7. Zoetis ZTS
8.4
8. Phibro Animal Health PAHC
7.98
9. Journey Medical DERM
7.18
10. Vifor Pharma G2AB.F
6.24
11. Avadel Pharmaceuticals AVDL
6.07
12. PetIQ PETQ
5.03
13. ANI Pharmaceuticals ANIP
3.9
14. Taro Pharmaceutical Industries TARO
3.87
15. ProPhase Labs PRPH
3.8
16. Ironwood Pharmaceuticals IRWD
3.72
17. Regencell Bioscience Holdings RGC
3.68
18. Linc LNC
3.5
19. Cronos Group CRON
3.47
20. Pacira BioSciences PCRX
3.28
21. Catalent CTLT
3.2
22. Green Thumb Industries R9U2.F
3.17
23. Elanco Animal Health ELAN
3.1
24. Zynerba Pharmaceuticals ZYNE
3
25. Embecta EMBC
2.97
26. Collegium Pharmaceutical COLL
2.91
27. OptiNose OPTN
2.55
28. Societal CDMO SCTL
2.41
29. Organogenesis Holdings ORGO
2.4
30. Relmada Therapeutics RLMD
2.33
31. Curaleaf Holdings CURLF
2.32
32. Cumberland Pharmaceuticals CPIX
2.31
33. Bausch Health Companies BHC
2.3
34. Amphastar Pharmaceuticals AMPH
2.29
35. Procaps Group PROC
2.14
36. SCYNEXIS SCYX
2
37. Emergent BioSolutions EBS
1.99
38. Alpha Teknova TKNO
1.97
39. Eagle Pharmaceuticals EGRX
1.94
40. Solid Biosciences SLDB
1.88
41. Theratechnologies THTX
1.87
42. Jupiter Wellness JUPW
1.84
43. Tilray Brands TLRY
1.81
44. Ascend Wellness Holdings AAWH
1.76
45. Flora Growth FLGC
1.74
46. Universe Pharmaceuticals UPC
1.74
47. Biofrontera BFRI
1.68
48. Neoleukin Therapeutics NLTX
1.57
49. Teva Pharmaceutical Industries TEVA
1.52
50. Evolus EOLS
1.51
51. Clever Leaves Holdings CLVR
1.47
52. Ayr Wellness 3KJB.F
1.41
53. Amneal Pharmaceuticals AMRX
1.11
54. Harrow Health HROW
0.4
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.